Catalent
AcquiredLeading Global CDMO Pharma Solutions
United States · Founded 2007
- Headquarters
- New Jersey
- Employees
- 10001+
- Founded
- 2007
- Business Model
- B2B
- Website
- catalent.com
- Acquisition Date
- Jan 2024
About
Catalent partners with pharmaceutical, biotechnology, and consumer health companies to develop, manufacture, and deliver medicines, therapies, and other products. Its integrated services span small molecules, biologics, cell and gene therapies, and clinical supply. The company supports customers from early-stage design through commercial manufacturing, combining advanced technologies, global scale, and technical expertise.
Summary
Catalent is a Biotech company based in United States, founded in 2007. Investors include Novo Holdings A/S.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Jan 2024
Sign up to see all 2 events
Funding, valuations, and company events, with amounts and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/catalent"><img src="https://indexed.vc/api/badge/company/catalent" alt="Catalent on Indexed.vc" width="260" height="76" /></a>